CTOs on the Move

Hanna Instruments

www.hannaist.com

 
Hanna Instruments is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.hannaist.com
  • 3820 Packard St Ste 120
    Ann Arbor, MI USA 48108
  • Phone: 401.765.0045

Executives

Name Title Contact Details

Similar Companies

Vantage Outsourcing

Vantage Outsourcing is a Effingham, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Association of California Healthcare Districts

Association of California Healthcare Districts is a Rancho Cordova, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hemispherx Biopharma

Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. Its products include Ampligen, which is under clinical development for the treatment of Chronic Fatigue Syndrome, Hepatitis B, human immunodeficiency virus (HIV), renal cell carcinoma, and malignant melanoma; Alferon N Injection, an injectable formulation of natural alpha interferon for the treatment of certain categories of genital warts; and Alferon LDO, a low-dose oral liquid formulation of natural alpha interferon for the treatment of influenza and other emerging viral diseases. Hemispherx Biopharma, Inc. was founded in 1990 and is headquartered in Philadelphia, Pennsylvania.

City of Gahanna

City of Gahanna, located in central ohio, offers family events, great parks and communities, plus the activities and businesses found at Creekside. Learn more about business development, emergency services, legislation, mayor’s court, city council, zon...

Kedalion Therapeutics

Kedalion Therapeutics is a clinical-stage, venture-funded ophthalmic drug company based in Menlo Park, CA. Kedalions AcuStream technology delivers topical drugs to the eye in a precise and accurate manner that enables comparable efficacy with an 80% reduction in dose compared to standard drops, and a significantly improved side effect profile along with patient comfort and convenience following self-administration.